{
  "reasoning": "The original query focuses on the affordability and access to generic drugs in Africa, highlighting economic conditions and specific examples like the cost disparity between patented and generic versions of Glivec. The intent appears informational, aiming to explore how affordable medications can improve health outcomes amid wealth inequality. Existing results emphasize various impacts of generics but lack depth regarding local production capacity, socioeconomic factors beyond drug pricing, and solutions for these challenges. To enhance this search query, a conceptual graph will be constructed with core concepts from the query at its center, branching out into relevant expansions that address identified weaknesses. The goal is to uncover high-value terms related to economic policies, healthcare infrastructure, and regional production capabilities. Through thoughtful expansion of the query via paths like hierarchical terms (e.g., broader economic implications), contextual terms (settings/scenarios impacting drug access), and domain-specific terminology (e.g., health policy in Africa), new angles will be explored to provide a more comprehensive understanding.",
  "query_goals": [
    "Understand the impact of generic drugs on healthcare affordability in Africa",
    "Explore socioeconomic factors affecting drug accessibility beyond pricing",
    "Identify local production capacity for generic medications within African countries"
  ],
  "augmented_query": "Easily affordable drugs mean greater access; Generic drugs are much cheaper to produce, ideal for Africa's struggling population. While GDP growth exists in Africa, wealth distribution is unequal\u201453% feel economically poor, limiting high-cost drug purchases. Generic medications reduce prices, enhancing affordability. Glivec costs \u00a348.62/400mg, while its Indian generic equivalent costs \u00a34.82. Increased access boosts treatment levels, reducing death from preventable diseases. Examine economic development policies in Africa, healthcare infrastructure improvements, local pharmaceutical manufacturing capabilities, wealth distribution, and public health policy interventions.",
  "ndcg": {
    "NDCG@10": 0.63093,
    "NDCG@100": 0.63093,
    "NDCG@1000": 0.63093,
    "NDCG@10000": 0.63093
  },
  "map": {
    "MAP@10": 0.5,
    "MAP@100": 0.5,
    "MAP@1000": 0.5,
    "MAP@10000": 0.5
  },
  "recall": {
    "Recall@10": 1.0,
    "Recall@100": 1.0,
    "Recall@1000": 1.0,
    "Recall@10000": 1.0
  },
  "precision": {
    "P@10": 0.1,
    "P@100": 0.01,
    "P@1000": 0.001,
    "P@10000": 0.0001
  },
  "delta": 0.13093,
  "instruction": "graph",
  "query": "Easily affordable drugs will mean greater access  Generic drugs are much cheaper to produce, which is ideal for Africa\u2019s struggling population. While there has been significant gross domestic product (GDP) growth in Africa, the actual distribution of wealth is relatively unequal. According to Afrobarometer, 53% of Africans still feel that their economic condition is poor [1] . This restricts their ability to purchase high cost drugs. Generic medication would reduce the price of these drugs, making them affordable to the average citizen. The patented drug Glivec, used for cancer treatment, costs \u00a348.62 for 400 mg in South Africa while its generic equivalent (produced in India) costs \u00a34.82 [2] . Increased access will result in higher levels of treatment, which in turn will reduce death rates from preventable diseases in Africa.  [1] Hofmeyr, Jan, \u2018Africa Rising? Popular Dissatisfaction with Economic Management Despite a Decade of Growth\u2019  [2] Op Cit",
  "query_id": "test-health-dhiacihwph-pro01a",
  "generator_model": "ollama_chat/phi4:14b-q8_0",
  "temperature": 1.0,
  "dataset": "arguana",
  "node_classes": [
    "Generic Drugs",
    "Economic Conditions",
    "Healthcare Access",
    "Regional Production",
    "Policy Solutions",
    "Wealth Distribution",
    "Market Dynamics",
    "Drug Safety and Efficacy",
    "Health Outcomes"
  ],
  "query_nodes": [
    "Affordable drugs",
    "Generic drugs",
    "GDP growth in Africa",
    "Economic condition in Africa",
    "Glivec vs generic drug pricing"
  ],
  "nearest_neighbors": [
    "Economic development policies in Africa",
    "Healthcare infrastructure improvements",
    "Local pharmaceutical manufacturing capabilities",
    "Distribution of wealth and economic inequality",
    "Generic drug production regulations",
    "Impact of affordable healthcare on mortality rates",
    "Role of international trade in generic drugs",
    "Public health policy interventions",
    "Collaborations for local drug production",
    "Market dynamics affecting drug pricing"
  ],
  "cleaned_augmented_query": "easily affordable drugs mean greater access generic much cheaper produce ideal africa struggling population gdp growth exists wealth distribution unequal 53 feel economically poor limiting high cost drug purchases medications reduce prices enhancing affordability glivec costs 48 62 400mg indian equivalent 4 82 increased boosts treatment levels reducing death preventable diseases examine economic development policies healthcare infrastructure improvements local pharmaceutical manufacturing capabilities public health policy interventions",
  "final_delta": 0.13093,
  "initial_results": "### Text snippet from document at k=1\n: Most vital drugs are already generic  Many drugs which are used in the treatment of HIV, malaria and cancer are already generic drugs which are produced in their millions [1] . This removes the necessity to provide further high quality generic drugs as there is already an easily accessible source of pharmaceuticals. Effective treatments for Malaria, in conjunction with prevention methods, have resulted in a 33% decrease in African deaths from the disease since 2000 [2] . The drugs responsible for this have been readily available to Africa, demonstrating a lack of any further need to produce pharmaceuticals for the continent.  [1] Taylor,D. \u2018Generic-drug \u201csolution\u201d for Africa not needed\u2019  [2] World Health Organisation \u201910 facts on malaria\u2019, March 2013\n\n### Text snippet from document at k=2\n: Some countries, such as India and Thailand, have specialised in producing generic drugs. These states provide the majority of generic drugs to Africa. This removes the burden of other countries to supply Africa with their own drugs whilst potentially damaging their own research companies. India has managed to create a very profitable industry based around cheap generic drugs which it mainly exports to the African continent [1] , decreasing the necessity of other states to contribute vast resources.  Providing generics to Africa will not damage development by the big pharmaceutical companies as at the moment these countries cannot afford the drugs so are not a market. The drugs are researched on the assumption that they will be sold in the developed world. What matters therefore is to ensure that generics for Africa don\u2019t get sold back to the developed world undercutting patented drugs.  [1] Kumar,S. \u2018India, Africa\u2019s Pharma\u2019\n\n### Text snippet from document at k=10\n... In private health care systems, this drives up insurance premiums, thereby pricing large numbers of people out of health care coverage (44 million Americans have no coverage, despite the United States spending more per capita on health care than any other country). Alternatively, it forces many people to select insurance packages with lower levels of coverage (the solution introduced in 2005 by the Bush administration). The EU has estimated that its member states with public healthcare systems would be crippled if they spent as much on drugs as the United States [1] .  Actually estimates in the United Kingdom state that, by buying generic drugs, the public health care system could save more than \u00a3300m a year. General practioners could make more use of cheaper, non-brand versions of the drugs, without harming care. An example of the NHS overpricing drugs: one treatment for gastric problems, Omeprazole, can be bought from wholesalers for between \u00a32.50 and \u00a33.40, yet the NHS pays \u00a310.85 every time it is prescribed. To make the matter worse, doctors often over-prescribe; at least \u00a3100m could be saved if they were more careful in this matter. [2]  Therefore, because it would create a substantial financial burden to the current public health care system, allowing advertising would be a bad idea.  [1] Heath Care in the United States.   [2] BBC News, Drug profiteering claims denied, published 03/14/2004,  , accessed 07/30/2011\n",
  "thought_process": "Looking at the original query, \"Easily affordable drugs will mean greater access...,\" this makes me think of how the cost of medications can be a significant barrier to healthcare access, especially in regions with limited economic resources like Africa. Though the user might actually be trying to explore the broader implications of generic drug availability on public health, I'm not sure yet how deep they want to dive into economic policies, local production capabilities, or the intricacies of healthcare infrastructure.\n\nAnalyzing the results of the original query, I notice that while there's a good discussion on the cost-effectiveness of generic drugs and some mention of economic conditions in Africa, there's a lack of depth regarding local production capacity, socioeconomic factors beyond drug pricing, and comprehensive solutions for these challenges. For instance, the snippet from the document at k=1 highlights that many vital drugs are already generic and widely available, which might reduce the need for additional generic drug production. However, it doesn't address how these drugs are distributed within Africa or the role of local production in enhancing accessibility.\n\nI'm seeing several possibilities here... Let me approach this using the conceptual graph traversal technique, which involves constructing a graph with core concepts from the query at its center and then branching out into relevant expansions. This should help because it systematically identifies related terms and concepts that can enhance the query, providing a more comprehensive view of the topic.\n\nFollowing the conceptual graph traversal approach, I first identify core concepts like \"generic drugs,\" \"affordability,\" \"Africa,\" \"healthcare access,\" and \"economic conditions.\" Then, I consider first-order connections such as the relationship between generic drugs and their impact on healthcare costs, as well as second-order connections like the influence of economic policies on drug affordability. Domain contexts, such as public health policy in Africa and international trade regulations, also play a crucial role.\n\nTo expand the query, I'll explore several paths. Firstly, hierarchical terms can help me understand broader concepts like \"healthcare systems\" and narrower concepts such as \"community health clinics.\" Secondly, compositional terms might include \"drug manufacturing processes\" or \"pharmaceutical supply chains.\" Contextual terms, like \"rural vs. urban healthcare access,\" can also provide valuable insights. Lastly, domain-specific terminology, such as \"essential medicines list\" or \"national drug policies,\" can deepen the query's relevance to public health in Africa.\n\nAs I apply the conceptual graph traversal technique, I realize that terms like \"economic development policies,\" \"healthcare infrastructure improvements,\" and \"local pharmaceutical manufacturing capabilities\" could significantly enhance the query. These terms not only relate directly to the original query but also address the identified weaknesses in the initial search results. For instance, exploring economic development policies can reveal how governments can support the local production of generic drugs, while examining healthcare infrastructure improvements can highlight the need for better drug distribution systems.\n\nWait, that's not quite right for this query. Let me adjust my approach to better fit the context. Considering the socioeconomic factors affecting drug accessibility beyond pricing, I should also look into \"wealth distribution,\" \"poverty rates,\" and \"education levels\" as these can influence healthcare outcomes. Additionally, terms related to \"international aid,\" \"non-governmental organizations (NGOs),\" and \"public-private partnerships\" in healthcare could provide insights into how external support can bolster local healthcare systems.\n\nThis step of the technique is revealing the importance of understanding the complex interplay between economic conditions, healthcare access, and the role of generic drugs. Which actually reminds me of the concept of \"universal health coverage\" and how it relates to the availability of affordable medications. I just had a realization that connects to what we were exploring earlier - the potential for local production of generic drugs to not only increase access but also to stimulate economic growth in Africa by creating jobs and reducing dependency on imported medications.\n\nFollowing the technique's steps systematically, I should next consider the nearest neighbors to our core concepts, such as \"generic drug production regulations,\" \"impact of affordable healthcare on mortality rates,\" and \"role of international trade in generic drugs.\" These can further refine our understanding of the barriers to and facilitators of generic drug accessibility in Africa.\n\nI need to consider the next step in the technique, which involves filtering terms based on relevance, distinctiveness, specificity, and searchability. However, I'm also noticing this interesting pattern where the discussion around generic drugs keeps touching on the issue of patent protection and its impact on drug pricing. This makes me think about the balance between encouraging innovation through patent protection and ensuring access to life-saving medications.\n\nThrough this process of applying the conceptual graph traversal technique and exploring related threads, I believe the terms that would be most effective for enhancing the query are those that capture both the explicit and implicit aspects of what the user is seeking. These include terms related to economic development, healthcare infrastructure, local production capabilities, and public health policy interventions. The final expanded query should reflect a balance between the structured approach of the technique and",
  "thought_generator": "openrouter/meta-llama/llama-3.3-70b-instruct"
}